Close
Nordic 9Nordic 9

Puhua Capital (investor - Venture Capital)

China puhuacapital.com
See something wrong or missing? Let us know
Offices:Hangzhou

Puhua Capital is a venture company from China.

Average round investment:101.5M USD
Average number per year:1.0
Distribution: 2022 (1)2021 (1)2020 (1)
Portfolio companies: United Kingdom Ori BiotechUnited Kingdom bit.bioUnited Kingdom Congenica
Mostly invests in: United Kingdom United Kingdom (3) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Puhua Capital

Name Criteria
United States Arch Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Oxford Technology and Innovations EIS Fund
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Luxembourg CVC Capital Partners
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Cleveland Avenue
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Redmile Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Leaps by Bayer
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Sweden Summa Equity
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United States Charles River Laboratories
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States National Resilience
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China GT Healthcare Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top